These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 1728834

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Double-blind evaluation of mazindol in refractory obesity.
    Smith RG, Innes JA, Munro JF.
    Br Med J; 1975 Aug 02; 3(5978):284. PubMed ID: 1097046
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mazindol: its efficacy and mode of action in generating weight loss.
    Johnson WG, Hughes JR.
    Addict Behav; 1979 Aug 02; 4(3):237-44. PubMed ID: 495247
    [No Abstract] [Full Text] [Related]

  • 9. Double blind cross-over study of a new appetite suppressant AN 448.
    Haugen HN.
    Eur J Clin Pharmacol; 1975 Aug 02; 8(1):71-4. PubMed ID: 786676
    [Abstract] [Full Text] [Related]

  • 10. [Effects of an anorexiant, mazindol, on metabolic abnormalities of rats with ventromedial hypothalamic lesions].
    Inoue S, Egawa M, Satoh S.
    Nihon Yakurigaku Zasshi; 1984 May 02; 83(5):441-9. PubMed ID: 6469133
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Slowed gastric evacuation accounts for the reduction of food intake by anorectic drugs.
    Jonderko K, Kucio C, Skrzypek D.
    Eur J Clin Nutr; 1988 Jul 02; 42(7):627-31. PubMed ID: 3066620
    [Abstract] [Full Text] [Related]

  • 14. Effect of anorexiant drugs on growth hormone secretion in obese children.
    Baritussio A, Enzi G, Rigon G, Molinari M, Inelmen EM, Crepaldi G.
    Pharmacol Res Commun; 1978 Jun 02; 10(6):529-40. PubMed ID: 693565
    [No Abstract] [Full Text] [Related]

  • 15. A comparison of mazindol (Teronac) with diethylpropion in the treatment of exogenous obesity.
    Murphy JE, Donald JF, Molla AL, Crowder D.
    J Int Med Res; 1975 Jun 02; 3(3):202-6. PubMed ID: 162676
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A multicentre study comparing mazindol and placebo in obese patients.
    Walker BR, Ballard IM, Gold JA.
    J Int Med Res; 1977 Jun 02; 5(2):85-90. PubMed ID: 326596
    [Abstract] [Full Text] [Related]

  • 20. [Drug therapy in obesity].
    Ishii J.
    Nihon Rinsho; 1988 Nov 02; 46(11):2491-6. PubMed ID: 3241376
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.